NOVEMBER 18, 2008 -- PLC Systems (Franklin, MA), a company focused on cardiac and vascular medical device-based technologies, says that its common stock is now trading on the over the counter bulletin board market under the symbol "PLCSF," following receipt of approval by the Financial Industry Regulatory Authority (FINRA).
PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. CO2 TMR offers a treatment option for angina patients who suffer from severe coronary artery disease. The CO2 Heart Laser is the world's first TMR angina relief device cleared for commercial distribution by both the U.S. Food and Drug Administration and Japanese Ministry of Health, Labor and Welfare, and to obtain a CE Mark for distribution within the EU.
More information:
PLC Systems Inc.